Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-01-17

FDA Approved: ONDANSETRON — Supplemental Application (ACTAVIS PHARMA, INC.)

View source ↗

Summary

FDA approved a supplemental application for ondansetron tablets from Actavis Pharma, Inc., adding a generic ondansetron tablet product to the market.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ondansetron (ondansetron)

Snippet

SUPPL AP for ONDANSETRON (ONDANSETRON)